2025 International Congress Archives

Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus

S. Park (Daejeon, Republic of Korea)
Uncovering the heterogeneity of spatiotemporal trajectories of neurodegeneration in Parkinson’s disease: an early-phase 18F-FP-CIT PET study

SJ. Chung, J. Lee, Y. Choi, J. Jang, HK. Na, PH. Lee (Seoul, Republic of Korea)
Underlying Diseases in a Patient with Upper Limb Clumsiness Suspected of Corticobasal Degeneration

J. Nunomura (Aomori, Japan)
Understanding Family and Clinician Perspectives on Treatment Decision-Making for Acute Dystonia Exacerbations in Children

L. Vogt, A. Leblanc-Millar, S. Breitbart, N. Al Azri, A. Fasano, K. Nelson, C. Gorodetsky (Toronto, Canada)
Understanding Referral Patterns to a Pediatric Movement Disorders Clinic: A Quality Improvement Project

A. Leblanc-Millar, C. Gorodetsky (Toronto, Canada)
Understanding the Challenges of Treating and Living with Essential Tremor: Results from a Lived-Experience Focus Group

R. Martuscello, L. Knight, I. Pyle, A. Sanchez Fraga, C. Ferrer, K. Gant, A. Grinspan (Miami, USA)
Understanding the relationship between synaptic density and dopamine transporter availability in Parkinson’s disease

F. Ebrahimian Sadabad, T. Volpi, P. Honhar, S. Tinaz, M. Dias, T. Toyonaga, M. Naganawa, J. Gallezot, Y. Yang, W. Ibrahim, S. Cayir, R. Radhakrishnan, G. Angarita, S. Holmes, R. Comley, R. Carson, S. Finnema, D. Matuskey (New Haven, USA)
Undescribed Variant of the THAP1 Gene Likely Pathogenic Associated with DYT6 – Case Report

J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, D. Dos Santos, C. Habekost, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)
Unilateral focused ultrasound subthalamotomy in early Parkinson’s disease: randomized-controlled trial protocol

R. Martinez-Fernandez, MC. Rodriguez Oroz, S. Paschen, C. Juri, M. Del Alamo, E. Natera-Villalba, R. Rodriguez-Rojas, LH. Gonzalez-Quarante, M. Synowitz, J. Lorenzoni, CA. Sánchez-Catasús, S. Obika, T. Jimenez-Castellanos, P. Reiters, E. Cerutti, RA. Villino-Boquete, C. Ferrer, O. Rascol, G. Deuschl, JA. Obeso (Madrid, Spain)
Unmasking Wilson Disease: Subacute Neurological Complications During the COVID-19 Pandemic

BY. Chen (Tainan, Taiwan)
Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)
Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)
Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)
Unraveling the Estrogen-Parkinson’s Disease Link: Methodological Challenges in Meta-Analyzing Reproductive Factors and PD Risk.

EP. Papathoma, TN. Ntetsika, TS. Soumala, IM. Markaki (Solna, Sweden)
Unraveling the Genetic Architecture of Progressive Supranuclear Palsy in East Asians

P. Chen, R. Lin, N. Lee, J. Hsu, C. Tai, R. Wu, H. Chiang, Y. Wu, C. Lu, H. Chang, T. Lee, Y. Chang, C. Lin (Taipei, Taiwan)
Unraveling the Intertwined Relationship of DBS, Parkinson’s Disease Subtype and LEDD: A Retrospective Study

T. Mehta, V. Lavu, C. Hess, A. Ramirez-Zamora, M. Okun, J. Wong (Gainesville, USA)
Unraveling the Variability in Amantadine Response for Levodopa-Induced Dyskinesias: The Impact of Clinical and Genetic Factors

L. Saadatpour, H. Chaparro-Solano, J. Yu, C. Sonneborn, C. Piccinin, S. Anis, E. Assaedi, P. Coss, S. Horn, O. Vaou, I. Mata, H. Fernandez (San Antonio, USA)
Unravelling The Relationship Between Autonomic Nervous System And Anxiety In People With Parkinson’s Disease

L. Ricciardi, A. Fanciulli, F. Cucinotta, B. Ishahara, I. Cociasu, F. Baig, E. Pereira, M. Hart, F. Morgante, E. Makovac (London, United Kingdom)
Unsupervised Analysis and Clustering of 3D Parkinsonian Gait

S. Lyu, KD. Kim, T. Dunn (Durham, USA)
Unusual presentation of POLR3A-associated leukodystrophy – two cases reported

N. Mazalica, A. Milovanovic, M. Sarcevic, A. Tomic, V. Markovic, M. Brankovic, A. Marjanovic, N. Dragasevic-Miskovic (Belgrade, Serbia)
Unveiling a rare case: Novel TBK1 variant presenting as Multiple system atrophy-like phenotype

R. Kandadai, M. Karri, S. Kola, R. Borgohain, R. Alugolu, P. Vvsrk, A. Nalamasa (Hyderabad, India)
Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)
Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)
Updated Meta-analysis Assessing GLP-1 Agonists for Parkinson’s Disease

M. Messak, A. Abdelmageed, Y. Khattab (Helwan, Egypt)
Updates on Perception of Patients with Cervical Dystonia in Residents and Medical Students

M. Patel, D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, P. Sheehan, A. Memon, M. Moreno-Escobar, A. Murray, G. Pawar, J. Frey (Morgantown, USA)
Upper Limb Tremor Suppression Using Targeted High Frequency Peripheral Nerve Stimulation

V. Ganesh, X. Xue, D. Roque, N. Sharma (Raleigh, USA)
Uremic Striatopallidal Syndrome Manifesting As Acute Onset Chorea

R. Cruz Vicioso, J. Carbonell, C. Pérez (SANTO DOMINGO, Dominican Republic)
Usability Evaluation of a Web-based Interface for Self-Management, Remote Monitoring and Timely Review for Parkinson’s Disease (SMaRT-PD)

K. Bounsall, P. Onyeachu, M. Humphries, C. Maycock, V. Haunton, V. Allgar, C. Carroll (Plymouth, United Kingdom)
Use of Botulinum Toxin Application in the Inferior Oblique Capitis Muscle Under Tomographic Guidance in Cervical Dystonia Report of Two Cases

I. Amorín, A. Rodriguez, N. Sorondo, B. Cardozo (Montevideo, Uruguay)
Using Chronic DBS Brain Sensing Data to Develop an AI-based Engine for Clinical Insights

E. Fehrmann, A. Nourmohammadi, R. Molina, C. Zarns, M. Case, A. Becker, R. Raike (Minneapolis, USA)
Using large language models to assess dynamics in semantic memory search of patients with Parkinson’s disease

F. Toro Hernández, R. Cabral-Carvalho, N. Mendes Pellegrino, G. Paris-Colombo, A. Bontempo, A. Sena, H. Salmazo-Silva, M. Carthery-Goulart (São Paulo, Brazil)
Using Multi-Generational High-Risk Pedigrees to Identify Candidate Parkinson’s Disease Predisposition Genes

P. Moretti, K. Allen-Brady, J. Stevens, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, USA)
Using R and Python for Kinematic Analysis in Robotic-Assisted Balance Training: A Review of Methodologies and Outcomes

M. Ali, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, M. M. Elsayed (Mansoura, Egypt)
Using Zebrafish Model to Investigate Complex Hereditary Spastic Paraplegia Caused by EPT1 Variants

S. Wang, S. Banka, M. Lowe, A. Nicolaou (Manchester, United Kingdom)
Utilising Beta Power in Local Networks to Predict Freezing of Gait Events in Parkinson’s Disease

Y. Tian, E. Matar, S. Lewis (Sydney, Australia)
Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt

N. Shebl, S. Mondal, F. Waheed, A. Farag, N. Abonar, M. Abdelhady, S. Asran, M. Salama, M. Rizig (Cairo, Egypt)
Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease

M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie (Chicago, USA)
Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center

S. Anis, A. Kundrick, C. Piccinin, T. Lopez-Gonzalez, D. Dos Santos, H. Fernandez (Cleveland, USA)
Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy

F. Nery, T. Nevmyrych, J. Murphy, S. Wu, Y. Zabar, A. Gafson, S. Bullain, J. O’Gorman (Cambridge, USA)
Utilizing the Global Parkinson’s Genetics Program (GP2) to develop a precision medicine recruitment protocol

K. Atterling Brolin, YY. Beh, P. Saffie Awad, J. Aviles, A. Pajo, E. Navarro-Jones, C. Klein, I. F. Mata, K. Paquette, H. Iwaki, L. Jones, H. Leonard, N. Okubadejo, C. Blauwendraat, L. Screven, A. Noyce, M. Toffoli, AH. Tan, H. Morris, M. Nalls (Lund, Sweden)
Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series

M. da Silva, C. Ternes, B. de Lima, R. Mesquita, L. Moriyama (Campinas, Brazil)
Utilizing Virtual Reality in Educational Programs for Parkinson’s Disease Rehabilitation: A Review of Current Literature and Future Directions

S. A. Hassan, Y. Mohamed, M. Abouelseoud, A. Alaa, A. Hafez, M. M. Elsayed (Giza, Egypt)